» Articles » PMID: 32016318

Variation Benchmark Datasets: Update, Criteria, Quality and Applications

Overview
Specialty Biology
Date 2020 Feb 5
PMID 32016318
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Development of new computational methods and testing their performance has to be carried out using experimental data. Only in comparison to existing knowledge can method performance be assessed. For that purpose, benchmark datasets with known and verified outcome are needed. High-quality benchmark datasets are valuable and may be difficult, laborious and time consuming to generate. VariBench and VariSNP are the two existing databases for sharing variation benchmark datasets used mainly for variation interpretation. They have been used for training and benchmarking predictors for various types of variations and their effects. VariBench was updated with 419 new datasets from 109 papers containing altogether 329 014 152 variants; however, there is plenty of redundancy between the datasets. VariBench is freely available at http://structure.bmc.lu.se/VariBench/. The contents of the datasets vary depending on information in the original source. The available datasets have been categorized into 20 groups and subgroups. There are datasets for insertions and deletions, substitutions in coding and non-coding region, structure mapped, synonymous and benign variants. Effect-specific datasets include DNA regulatory elements, RNA splicing, and protein property for aggregation, binding free energy, disorder and stability. Then there are several datasets for molecule-specific and disease-specific applications, as well as one dataset for variation phenotype effects. Variants are often described at three molecular levels (DNA, RNA and protein) and sometimes also at the protein structural level including relevant cross references and variant descriptions. The updated VariBench facilitates development and testing of new methods and comparison of obtained performances to previously published methods. We compared the performance of the pathogenicity/tolerance predictor PON-P2 to several benchmark studies, and show that such comparisons are feasible and useful, however, there may be limitations due to lack of provided details and shared data. Database URL: http://structure.bmc.lu.se/VariBench.

Citing Articles

Benchmarking, detection, and genotyping of structural variants in a population of whole-genome assemblies using the SVGAP pipeline.

Hu M, Wan P, Chen C, Tang S, Chen J, Wang L bioRxiv. 2025; .

PMID: 39975360 PMC: 11839052. DOI: 10.1101/2025.02.07.637096.


Exploring the Applications of Explainability in Wearable Data Analytics: Systematic Literature Review.

Abdelaal Y, Aupetit M, Baggag A, Al-Thani D J Med Internet Res. 2024; 26():e53863.

PMID: 39718820 PMC: 11707450. DOI: 10.2196/53863.


AI-derived comparative assessment of the performance of pathogenicity prediction tools on missense variants of breast cancer genes.

Ahmad R, Ali B, Al-Jasmi F, Al Dhaheri N, Al Turki S, Kizhakkedath P Hum Genomics. 2024; 18(1):99.

PMID: 39256852 PMC: 11389290. DOI: 10.1186/s40246-024-00667-9.


Simulation Tests of Methods in Evolution, Ecology, and Systematics: Pitfalls, Progress, and Principles.

Lotterhos K, Fitzpatrick M, Blackmon H Annu Rev Ecol Evol Syst. 2023; 53(1):113-136.

PMID: 38107485 PMC: 10723108. DOI: 10.1146/annurev-ecolsys-102320-093722.


Machine Learning-Guided Protein Engineering.

Kouba P, Kohout P, Haddadi F, Bushuiev A, Samusevich R, Sedlar J ACS Catal. 2023; 13(21):13863-13895.

PMID: 37942269 PMC: 10629210. DOI: 10.1021/acscatal.3c02743.


References
1.
Li S, Vera Alvarez R, Sharan R, Landsman D, Ovcharenko I . Quantifying deleterious effects of regulatory variants. Nucleic Acids Res. 2016; 45(5):2307-2317. PMC: 5389506. DOI: 10.1093/nar/gkw1263. View

2.
Niroula A, Urolagin S, Vihinen M . PON-P2: prediction method for fast and reliable identification of harmful variants. PLoS One. 2015; 10(2):e0117380. PMC: 4315405. DOI: 10.1371/journal.pone.0117380. View

3.
Schwarz J, Cooper D, Schuelke M, Seelow D . MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014; 11(4):361-2. DOI: 10.1038/nmeth.2890. View

4.
Li J, Zhao T, Zhang Y, Zhang K, Shi L, Chen Y . Performance evaluation of pathogenicity-computation methods for missense variants. Nucleic Acids Res. 2018; 46(15):7793-7804. PMC: 6125674. DOI: 10.1093/nar/gky678. View

5.
Pires D, Ascher D, Blundell T . mCSM: predicting the effects of mutations in proteins using graph-based signatures. Bioinformatics. 2013; 30(3):335-42. PMC: 3904523. DOI: 10.1093/bioinformatics/btt691. View